Home › Funds › ANTIPODES PARTNERS Ltd › B
ANTIPODES PARTNERS Ltd position in B
BARRICK MNG CORP · Materials
ANTIPODES PARTNERS Ltd reported holding 3,280,102 shares of B (BARRICK MNG CORP) in its Q3 2026 13F filing — a position valued at US$133.4M, representing 2.46% of its reported portfolio and ranking #12 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed B holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ANTIPODES PARTNERS Ltd's B position evolved
ANTIPODES PARTNERS Ltd first disclosed a stake in B in Q2 2025 at 8,131,094 shares (US$169.3M). The position peaked in Q4 2025 at 4,475,725 shares, worth US$194.9M. Across 6 filings, ANTIPODES PARTNERS Ltd increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,280,102 shares valued at US$133.4M — a reduction of -557,875 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2025 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 8.13M | $169.30M | New |
| Q3 2025 | 5.63M | $184.42M | Reduce |
| Q4 2025 | 4.48M | $194.94M | Reduce |
| Q1 2026 | 4.06M | $165.42M | Reduce |
| Q2 2026 | 3.84M | $140.97M | Reduce |
| Q3 2026 | 3.28M | $133.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About B and 13F data
B (BARRICK MNG CORP) is a Materials company. 62 other funds we track also report a position in B — the largest reported positions include Capital International Investors (US$2.71B), VAN ECK ASSOCIATES CORP (US$2.60B), Arrowstreet Capital (US$1.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding B
- Capital International Investors 66.64M sh · $2.71B · Q3 2026
- VAN ECK ASSOCIATES CORP 64.00M sh · $2.60B · Q3 2026
- Arrowstreet Capital 34.38M sh · $1.26B · Q2 2026
- Fidelity International (FIL) 28.60M sh · $1.16B · Q3 2026
- First Eagle Investment Management 20.16M sh · $819.79M · Q3 2026
- MACKENZIE FINANCIAL CORP 20.02M sh · $813.89M · Q3 2026
- TD ASSET MANAGEMENT INC 17.76M sh · $731.57M · Q3 2026
- CIBC Asset Management Inc 17.57M sh · $718.61M · Q3 2026
- Ninety One UK Ltd 14.14M sh · $575.22M · Q3 2026
- Connor, Clark & Lunn Investment Management Ltd. 9.21M sh · $374.35M · Q3 2026
- BANK OF NOVA SCOTIA 7.86M sh · $319.69M · Q3 2026
- TD Waterhouse Canada Inc. 7.40M sh · $296.30M · Q3 2026
More on ANTIPODES PARTNERS Ltd
FAQ
How long has ANTIPODES PARTNERS Ltd held B?
ANTIPODES PARTNERS Ltd has disclosed B holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is ANTIPODES PARTNERS Ltd's current position in B?
As of Q3 2026, ANTIPODES PARTNERS Ltd holds 3.28M shares of B (BARRICK MNG CORP), valued at $133.41M, representing 2.46% of its reported portfolio and ranking #12.
Has ANTIPODES PARTNERS Ltd been buying or selling B?
In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd reduced its position in B. The position peaked in Q4 2025 at 4.48M shares.
Which other funds hold B?
Other major institutional holders of B include Capital International Investors, VAN ECK ASSOCIATES CORP, Arrowstreet Capital, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.